From Name:
From Email:
To Name:
To Email:

Optional Message:


Italy's Move To Fund Unapproved Use of Roche's Avastin Alarms the Industry

from FiercePharma

In the U.S. pushing drugs for unapproved uses has gotten companies into big trouble. In Italy, the opposite is now true. To save money, the government will pay for patients to be treated for an eye disease with Roche's Avastin, a drug not approved for that use, and has taken legal action against the Swiss drugmaker and marketing partner Novartis for steering physicians toward the pricier Lucentis, which is. Italy's approach, which may look appealing to other cash-strapped European countries, drew a sharp rebuke from both companies as well as Big Pharma in general. more


Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063